Compounds > carbon monoxide

carbon monoxide and fibrin

carbon monoxide has been researched along with fibrin in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Canter, LW; Hampton, JW; Kalmaz, EV; Nau, CA1
Janzon, L1
Chau, LY; Chen, YH; Chiang, MT; Tsai, HL1
George, JF; Kirklin, JK; Messinger, JD; Nielsen, VG1
Nielsen, VG1
Brzoska, T; Buczko, W; Chlopicki, S; Fedorowicz, A; Grochal, E; Kramkowski, K; Leszczynska, A; Mann, B; Mogielnicki, A; Motterlini, R; Urano, T1

Other Studies

6 other study(ies) available for carbon monoxide and fibrin

ArticleYear
Effect of carbon monoxide exposure on blood fibrinolytic activity in rabbits.
    Environmental research, 1977, Volume: 14, Issue:2

    Topics: Animals; Blood Coagulation; Carbon Monoxide; Carboxyhemoglobin; Fibrin; Fibrinogen; Fibrinolysis; Hemoglobins; Male; Oxyhemoglobins; Rabbits; Time Factors

1977
The effect of smoking and smoking cessation on peripheral circulation and fibrinolysis. A population study in 59-year-old men.
    Acta chirurgica Scandinavica. Supplementum, 1974, Volume: 451

    Topics: Arm; Blood Cell Count; Blood Circulation; Blood Coagulation; Blood Pressure; Carbon Monoxide; Factor VIII; Fibrin; Fibrinogen; Fibrinolysis; Follow-Up Studies; Health Education; Heart Rate; Hemoglobins; Humans; Leg; Male; Middle Aged; Platelet Adhesiveness; Smoking; Sweden; Thromboplastin; Time Factors

1974
Carbon monoxide-induced early thrombolysis contributes to heme oxygenase-1-mediated inhibition of neointimal growth after vascular injury in hypercholesterolemic mice.
    Journal of biomedical science, 2006, Volume: 13, Issue:5

    Topics: Animals; Apolipoproteins E; Carbon Monoxide; Carotid Artery, Common; Fibrin; Fibrinogen; Heme Oxygenase-1; Hypercholesterolemia; Inflammation; Male; Mice; Muscle Development; Muscle, Smooth, Vascular; Plasminogen Activator Inhibitor 1; Thrombosis; Transduction, Genetic

2006
Carbon monoxide releasing molecule-2 decreases thick diameter fibrin fibre formation in normal and Factor XIII deficient plasmas.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2010, Volume: 21, Issue:1

    Topics: Biopolymers; Blood Coagulation; Carbon Monoxide; Drug Resistance; Factor XIII Deficiency; Fibrin; Fibrinolysis; Humans; In Vitro Techniques; Microscopy, Electron; Organometallic Compounds; Plasma; Prodrugs

2010
The antifibrinolytic effects of carbon monoxide-releasing molecule-2 are fibrin and alpha2-antiplasmin dependent.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2010, Volume: 21, Issue:6

    Topics: alpha-2-Antiplasmin; Antifibrinolytic Agents; Blood Coagulation; Carbon Monoxide; Fibrin; Fibrinolysis; Humans; Organometallic Compounds; Streptokinase; Thrombelastography; Thromboplastin; Thrombosis; Tissue Plasminogen Activator

2010
Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
    Arteriosclerosis, thrombosis, and vascular biology, 2012, Volume: 32, Issue:9

    Topics: Animals; Arterial Occlusive Diseases; Blood Coagulation; Blood Gas Analysis; Blood Platelets; Blood Pressure; Boranes; Carbon Monoxide; Carbonates; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrin; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Green Fluorescent Proteins; Injections, Intravenous; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Confocal; Organometallic Compounds; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Prothrombin Time; Rats; Rats, Wistar; Solubility; Thrombosis; Time Factors; Venous Thrombosis; Water

2012